[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,038)

Search Parameters:
Keywords = anaesthesia

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
26 pages, 1292 KiB  
Article
Identification of Genetic Variants Associated with Hereditary Thoracic Aortic Diseases (HTADs) Using Next Generation Sequencing (NGS) Technology and Genotype–Phenotype Correlations
by Lăcrămioara Ionela Butnariu, Georgiana Russu, Alina-Costina Luca, Constantin Sandu, Laura Mihaela Trandafir, Ioana Vasiliu, Setalia Popa, Gabriela Ghiga, Laura Bălănescu and Elena Țarcă
Int. J. Mol. Sci. 2024, 25(20), 11173; https://doi.org/10.3390/ijms252011173 (registering DOI) - 17 Oct 2024
Abstract
Hereditary thoracic aorta diseases (HTADs) are a heterogeneous group of rare disorders whose major manifestation is represented by aneurysm and/or dissection frequently located at the level of the ascending thoracic aorta. The diseases have an insidious evolution and can be encountered as an [...] Read more.
Hereditary thoracic aorta diseases (HTADs) are a heterogeneous group of rare disorders whose major manifestation is represented by aneurysm and/or dissection frequently located at the level of the ascending thoracic aorta. The diseases have an insidious evolution and can be encountered as an isolated manifestation or can also be associated with systemic, extra-aortic manifestations (syndromic HTADs). Along with the development of molecular testing technologies, important progress has been made in deciphering the heterogeneous etiology of HTADs. The aim of this study is to identify the genetic variants associated with a group of patients who presented clinical signs suggestive of a syndromic form of HTAD. Genetic testing based on next-generation sequencing (NGS) technology was performed using a gene panel (Illumina TruSight Cardio Sequencing Panel) or whole exome sequencing (WES). In the majority of cases (8/10), de novo mutations in the FBN1 gene were detected and correlated with the Marfan syndrome phenotype. In another case, a known mutation in the TGFBR2 gene associated with Loeys–Dietz syndrome was detected. Two other pathogenic heterozygous variants (one de novo and the other a known mutation) in the SLC2A10 gene (compound heterozygous genotype) were identified in a patient diagnosed with arterial tortuosity syndrome (ATORS). We presented the genotype–phenotype correlations, especially related to the clinical evolution, highlighting the particularities of each patient in a family context. We also emphasized the importance of genetic testing and patient monitoring to avoid acute aortic events. Full article
Show Figures

Figure 1

Figure 1
<p>Genetic and dynamic (modifiable) risk factors for HTAD. VSCMs: vascular smooth muscle cells.</p>
Full article ">Figure 2
<p>The spectrum of genetic variants detected in patients with syndromic HTAD. <span class="html-italic">FBN1</span>: fibrillin 1; <span class="html-italic">TGFBR2:</span> transforming growth factor-beta receptor, type II; <span class="html-italic">SLC2A10</span>: solute carrier family 2 (facilitated glucose transporter), member 10.</p>
Full article ">Figure 3
<p>Family trees and data collected from patients with syndromic HTAD.</p>
Full article ">
15 pages, 2684 KiB  
Article
Effect of Unfractionated Heparin Dose on Complement Activation and Selected Extracellular Vesicle Populations during Extracorporeal Membrane Oxygenation
by Johannes Zipperle, Laurenz Vock, Gerhard Fritsch, Johannes Grillari, Marcin F. Osuchowski, Wolfgang Holnthoner, Herbert Schöchl, Rebecca Halbgebauer, Markus Huber-Lang, Nikolaus Hofmann, Vincenz Scharner, Mauro Panigada, Johannes Gratz and Giacomo Iapichino
Int. J. Mol. Sci. 2024, 25(20), 11166; https://doi.org/10.3390/ijms252011166 (registering DOI) - 17 Oct 2024
Abstract
Extracorporeal membrane oxygenation (ECMO) provides critical support for patients with severe cardiopulmonary dysfunction. Unfractionated heparin (UFH) is used for anticoagulation to maintain circuit patency and avoid thrombotic complications, but it increases the risk of bleeding. Extracellular vesicles (EVs), nano-sized subcellular spheres with potential [...] Read more.
Extracorporeal membrane oxygenation (ECMO) provides critical support for patients with severe cardiopulmonary dysfunction. Unfractionated heparin (UFH) is used for anticoagulation to maintain circuit patency and avoid thrombotic complications, but it increases the risk of bleeding. Extracellular vesicles (EVs), nano-sized subcellular spheres with potential pro-coagulant properties, are released during cellular stress and may serve as potential targets for monitoring anticoagulation, particularly in thromboinflammation. We investigated the impact of UFH dose during ECMO therapy at the coagulation–inflammation interface level, focusing on complement activation and changes in circulating large EV (lEV) subsets. In a post hoc analysis of a multicenter randomized controlled trial comparing two anticoagulation management algorithms, we examined lEV levels and complement activation in 23 veno-venous-ECMO patients stratified by UFH dose. Blood samples were collected at different time points and grouped into three phases of ECMO therapy: initiation (day 1), mid (days 3–4), and late (days 6–7). Immunoassays detected complement activation, and flow cytometry analyzed lEV populations with an emphasis on mitochondria-carrying subsets. Patients receiving <15 IU/kg/h UFH exhibited higher levels of the complement activation product C5a and soluble terminal complement complex (sC5b-9). Lower UFH doses were linked to increased endothelial-derived lEVs, while higher doses were associated with elevated RBC-derived and mitochondria-positive lEVs. Our findings suggest the potential theranostic relevance of EV detection at the coagulation–inflammation interface. Further research is needed to standardize EV detection methods and validate these findings in larger ECMO patient cohorts. Full article
(This article belongs to the Special Issue Characterization of Extracellular Vesicles in Disease)
Show Figures

Figure 1

Figure 1
<p>Unfractionated heparin (UFH) dose and sample size across groups at different timepoints of ECMO therapy. Sample size (N) at initiation (low: 8; high: 7), mid (low: 5; high: 4) and late (low: 10; high: 9). Data represent single measurements of each patient per day grouped by ECMO phase and UFH dose. One-way analyses of variance or Kruskal–Wallis tests were performed to compare doses across phases. Data are shown as boxes and whiskers representing the median and interquartile range. If not indicated otherwise by lines and asterisks, differences in groupwise comparisons are non-significant. * = <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 2
<p>Complement activation throughout ECMO treatment and in comparison to UFH dose regimens. Activated complement pathway components C3, C5 and sC5b-9 at absolute concentrations in plasma of ECMO patients at different timepoints of ECMO therapy (<b>A</b>–<b>C</b>). One-way analyses of variance or Kruskal–Wallis tests were performed to compare phases and doses. Data are shown as columns and whiskers representing mean and SD. Comparisons of UFH doses in all patients and at all time points undergoing ECMO (<b>D</b>–<b>F</b>). Data are plotted as columns and whiskers representing mean and SD. A Student <span class="html-italic">t</span>-test or Mann–Whitney test was performed to compare groups. Sample size (N) in ECMO phases: initiation (low: 8; high: 7), mid (low: 5; high: 4), and late (low: 10; high: 9). Sample size (N) in summary measures: UFH dose low: 23; UFH dose high: 20. If not otherwise indicated by lines and asterisks, differences in groupwise comparisons were non-significant. * = <span class="html-italic">p</span> &lt; 0.05; ** = <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>Annexin V+ events throughout the ECMO period and in comparison to UFH dose regimens, as analyzed by flow cytometry. Absolute and relative levels of Annexin V+ events in plasma of ECMO patients at different stages of ECMO therapy (<b>A</b>,<b>B</b>). One-way analyses of variance or Kruskal–Wallis tests were performed to compare phases and doses. Data are shown as columns and whiskers representing mean and SD. Effect of UFH dose on absolute and relative counts of Annexin V+ events in all patients and at all time points undergoing ECMO (<b>C</b>,<b>D</b>). Data are plotted as columns and whiskers representing mean and SD. A Student <span class="html-italic">t</span>-test or Mann–Whitney test was performed to compare groups. Sample size (N) in ECMO phases: initiation (low: 8; high: 7), mid (low: 5; high: 4), and late (low: 10; high: 9). Sample size (N) in summary measures: UFH dose low: 23; UFH dose high: 20. If not indicated otherwise by lines and asterisks, differences in groupwise comparisons were non-significant.</p>
Full article ">Figure 4
<p>Absolute (events/μL, upper row) and relative counts (% of Annexin V positive events, lower row) of lEV populations of different cellular origins throughout different phases of ECMO therapy (<b>A</b>–<b>E</b>). One-way analyses of variance or Kruskal–Wallis tests were performed to compare phases and doses. Data are shown as columns and whiskers representing mean and SD. Sample size (N) in ECMO phases: initiation (low: 8; high: 7), mid (low: 5; high: 4), and late (low: 10; high: 9). If not indicated otherwise by lines and asterisks, differences in groupwise comparisons were non-significant. RBCs (red blood cells); TF (tissue factor). ** = <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 5
<p>Absolute (events/μL, upper row) and relative counts (% of Annexin V positive events, lower row) of lEV populations of different cellular origins depending on anticoagulation regimens throughout ECMO therapy (<b>A</b>–<b>E</b>). Student <span class="html-italic">t</span>-tests or Mann–Whitney tests were performed to compare doses. Data are shown as columns and whiskers representing mean and SD. <span class="html-italic">p</span>-values below 0.1 are given to indicate trends. Sample size (N) in summary measures: UFH dose low: 23; UFH dose high: 20. If not indicated otherwise by lines and asterisks, differences in groupwise comparisons were non-significant.</p>
Full article ">Figure 6
<p>Absolute (events/μL) and relative count (% of Annexin V-positive events) of Mitochondria+ lEV populations throughout ECMO phases and in comparison to UFH dose regimens. Annexin V+- and MitoTracker DeepRed double-positive events in plasma of ECMO patients at different stages of ECMO therapy (<b>A</b>,<b>B</b>) and grouped by UFH dose (<b>E</b>,<b>F</b>). Annexin V+-, MitoTracker- DeepRed- and platelet CD42b-positive events in plasma of ECMO patients at different stages of ECMO therapy (<b>C</b>,<b>D</b>) and grouped by UFH dose (<b>G</b>,<b>H</b>). One-way analyses of variance or Kruskal–Wallis tests were performed to compare selected phases and doses. Data are shown as columns and whiskers representing mean and SD. A Student <span class="html-italic">t</span>-test or Mann–Whitney test was performed to compare groups based on UFH dose. Sample size (N) in ECMO phases: initiation (low: 8; high: 7), mid (low: 5; high: 4), and late (low: 10; high: 9). Sample size (N) in summary measures: UFH dose low: 23; UFH dose high: 20. If not indicated otherwise by lines and asterisks, differences in groupwise comparisons were non-significant. * = <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">
18 pages, 1548 KiB  
Article
Bedside Neuromodulation of Persistent Pain and Allodynia with Caloric Vestibular Stimulation
by Trung T. Ngo, Wendy N. Barsdell, Phillip C. F. Law, Carolyn A. Arnold, Michael J. Chou, Andrew K. Nunn, Douglas J. Brown, Paul B. Fitzgerald, Stephen J. Gibson and Steven M. Miller
Biomedicines 2024, 12(10), 2365; https://doi.org/10.3390/biomedicines12102365 - 16 Oct 2024
Viewed by 322
Abstract
Background: Caloric vestibular stimulation (CVS) is a well-established neurological diagnostic technique that also induces many phenomenological modulations, including reductions in phantom limb pain (PLP), spinal cord injury pain (SCIP), and central post-stroke pain. Objective: We aimed to assess in a variety of persistent [...] Read more.
Background: Caloric vestibular stimulation (CVS) is a well-established neurological diagnostic technique that also induces many phenomenological modulations, including reductions in phantom limb pain (PLP), spinal cord injury pain (SCIP), and central post-stroke pain. Objective: We aimed to assess in a variety of persistent pain (PP) conditions (i) short-term pain modulation by CVS relative to a forehead ice pack cold-arousal control procedure and (ii) the duration and repeatability of CVS modulations. The tolerability of CVS was also assessed and has been reported separately. Methods: We conducted a convenience-based non-randomised single-blinded placebo-controlled study. Thirty-eight PP patients were assessed (PLP, n = 8; SCIP, n = 12; complex regional pain syndrome, CRPS, n = 14; non-specific PP, n = 4). Patients underwent 1–3 separate-day sessions of iced-water right-ear CVS. All but four also underwent the ice pack procedure. Analyses used patient-reported numerical rating scale pain intensity (NRS-PI) scores for pain and allodynia. Results: Across all groups, NRS-PI for pain was significantly lower within 30 min post-CVS than post-ice pack (p < 0.01). Average reductions were 24.8% (CVS) and 6.4% (ice pack). CRPS appeared most responsive to CVS, while PLP and SCIP responses were less than expected from previous reports. The strongest CVS pain reductions lasted hours to over three weeks. CVS also induced substantial reductions in allodynia in three of nine allodynic CRPS patients, lasting 24 h to 1 month. As reported elsewhere, only one patient experienced emesis and CVS was widely rated by patients as a tolerable PP management intervention. Conclusions: Although these results require interpretative caution, CVS was found to modulate pain relative to an ice pack control. CVS also modulated allodynia in some cases. CVS should be examined for pain management efficacy using randomised controlled trials. Full article
(This article belongs to the Special Issue Emerging Trends in Neurostimulation and Neuromodulation Research)
Show Figures

Figure 1

Figure 1
<p>Brain activity associated with caloric vestibular stimulation (CVS). Stronger and better-replicated evidence of CVS-induced brain activation and deactivation is indicated by the darker red and blue tones, respectively. CVS activates—via vestibular pathways (indicated by black arrows)—contralateral structures including the anterior cingulate cortex, insular cortex, putamen in basal ganglia and various temporoparietal areas. Several of these brain regions have been implicated in pain processing [<a href="#B33-biomedicines-12-02365" class="html-bibr">33</a>,<a href="#B34-biomedicines-12-02365" class="html-bibr">34</a>,<a href="#B35-biomedicines-12-02365" class="html-bibr">35</a>,<a href="#B36-biomedicines-12-02365" class="html-bibr">36</a>,<a href="#B37-biomedicines-12-02365" class="html-bibr">37</a>].</p>
Full article ">Figure 2
<p>Mean pain intensity at baseline and up to 30 min post-CVS#1 and post-ice pack intervention for all patients who underwent both conditions (N = 34). Results revealed significantly lower pain ratings compared to baseline within 30 min post-CVS than post-ice pack intervention. Error bars designate standard deviations. * Results revealed significantly lower pain ratings compared to baseline within 30 min post-CVS than post-ice pack intervention.</p>
Full article ">Figure 3
<p>Case illustrations of pain and allodynia modulation by CVS: (<b>A</b>) CRPS-12—a case of ≥50% short-term pain reduction following CVS that had returned to baseline by 24 h. (<b>B</b>) CRPS-13—a case of ≥30–49% short-term pain reduction following CVS that became a ≥50% reduction by 24 h, returning to baseline by 1 week. (<b>C</b>) NPP-1—a case of ≥30–49% short-term pain reduction following CVS that became a ≥50% reduction by 24 h, still evident after 1 week. (<b>D</b>) CRPS-2—a striking case of ≥50% short-term allodynia reduction following CVS, completely ameliorated allodynia by 24 h, two further CVS sessions on consecutive days keeping allodynia at low levels, repeat reduction evident after CVS#3 and allodynia reported to be still low (2/10) a month later. (<b>E</b>) CRPS-6—a case of a short-lived increase in allodynia following CVS with amelioration of allodynia by 24 h and allodynia still absent after 1 week. (<b>F</b>) CRPS-11—a case of &lt;30% allodynia reduction following CVS that became a ≥50% allodynia reduction by 24 h, returning to baseline by 1 week and a repeatable reduction after a second CVS session.</p>
Full article ">Figure 4
<p>Tolerability and side effects of CVS and patient willingness to repeat the intervention if it reduced their pain by 50% or more for one week or one month (figure reprinted from [<a href="#B47-biomedicines-12-02365" class="html-bibr">47</a>]). Solid bars indicate the percentage of patients (<span class="html-italic">n</span> = 25 with formal tolerability data available), while dotted lines indicate the reported intensity of CVS-induced discomfort/pain and side effects. The vast majority of patients reported that despite finding the procedure uncomfortable or painful or experiencing side effects, they were willing to repeat the intervention if it helped their pain.</p>
Full article ">
15 pages, 20599 KiB  
Article
Ultrasound-Guided Deep Serratus Plane Block in Cat Cadavers (Felis catus): A Description of Dye and Contrast Media Distribution
by Gonzalo Polo-Paredes, Marta Soler, Francisco Gil, Francisco G. Laredo, Amalia Agut, Sara Carrillo-Flores and Eliseo Belda
Animals 2024, 14(20), 2978; https://doi.org/10.3390/ani14202978 (registering DOI) - 16 Oct 2024
Viewed by 241
Abstract
The serratus plane block is an ultrasound-guided anaesthetic technique that aims to provide analgesia to the lateral thoracic wall cranial to the 8th rib. This block can be performed in a superficial (between the latissimus dorsi and the serratus ventralis thoracis (SVT) muscles) [...] Read more.
The serratus plane block is an ultrasound-guided anaesthetic technique that aims to provide analgesia to the lateral thoracic wall cranial to the 8th rib. This block can be performed in a superficial (between the latissimus dorsi and the serratus ventralis thoracis (SVT) muscles) or deep plane (between the intercostales externi and the SVT muscles). This study aimed to assess the distribution and nerve staining of a mixture of 0.4 mL kg−1 of methylene blue and iopromide 50:50 performing a deep serratus plane (DSP) block at the level of the 5th rib. We hypothesise that this technique would be feasible and could stain the rami cutanei laterales (RCL) of the intercostales nerves cranial to the 8th rib in cat cadavers. This study was divided into two phases. Phase 1 consisted of an anatomical study of the thoracic wall (2 cadavers). Phase 2 consisted of the ultrasound-guided injection of the aforementioned mixture and the assessment of its distribution by computed tomography and anatomical dissection (12 cadavers). Contrast media spread a median of 5.5 (2.5–7.5) intercostal spaces. The dye stained a median of 3 (0–5) RCL, affecting RCL 2 (17.39%), RCL 3 (57.17%), RCL 4 (78.26%), RCL 5 (91.30%), RCL 6 (78.26%), and RCL 7 (8.70%) within the DSP. Occasionally, the rami dorsales laterales and the thoracicus longus nerve were stained. Based on these findings, the DSP block performed with a volume of 0.4 mL kg−1 of an anaesthetic could provide analgesia in the area innervated from T4 to T6. Full article
(This article belongs to the Section Veterinary Clinical Studies)
Show Figures

Figure 1

Figure 1
<p>Ultrasound probe position to perform the deep serratus plane block. The probe is positioned at the level of the acromion, transversal to the ribs. The needle is advanced “in plane” in a caudo-cranial direction. D, dorsal; V, ventral; Cr, cranial; Cd, caudal.</p>
Full article ">Figure 2
<p>Schematic representation of the ultrasound image of the lateral aspect of the thoracic wall. The rami cutanei laterales emerge from the intercostales nerves and travel laterally towards the epidermis. The ribs produce an acoustic shadowing and the endothoracic fascia (blue dotted line), parietalis (orange dotted line), and visceralis (green dotted line) pleuras are seen as a hyperechoic line. R4–R6, ribs 4–6; L, lateral; Cr, Cranial; Cd, Caudal; M, medial.</p>
Full article ">Figure 3
<p>Ultrasound imaging and execution of the deep serratus plane block. (<b>A</b>) The needle is advanced “in plane” until contact with the R5 at its caudo-lateral border. (<b>B</b>) An anechoic pocket (green asterisks) is formed after injecting the mixture of methylene blue and iopromide between the serratus ventralis thoracis muscle and the ribs/intercostales externi muscles. R5, fifth rib; R6, sixth rib; L, lateral; Cr, cranial; Cd, caudal; M, medial.</p>
Full article ">Figure 4
<p>Superficial plane of the serratus ventralis thoracis (SVT) muscle in a cat cadaver dissection. The scapula and superficial muscle layers lateral to the SVT have been lateralized. The rami cutanei laterales of the intercostales nerves are observed between the serrations of the SVT. (<b>A</b>) Anatomical visualisation. (<b>B</b>) Schematic drawing of the anatomical structures. D, dorsal; Cr, cranial; Cd, caudal; V, ventral.</p>
Full article ">Figure 5
<p>Deep plane of the serratus ventralis thoracis muscle (detached from its insertion) in a cat cadaver dissection. The rami cutanei laterales are seen emerging caudal to their respective ribs. (<b>A</b>) Anatomical visualisation. (<b>B</b>) Schematic drawing of the anatomical structures. D, dorsal; Cr, cranial; Cd, caudal; V, ventral.</p>
Full article ">Figure 6
<p>Contrast media distribution pattern of the 23 hemithoraces subjected to CT scan after performing the ultrasound-guided deep serratus plane block with 0.4 mL kg<sup>−1</sup> of a mixture of iopromide and methylene blue. Twenty-three hemithoraces are represented in purple by their respective distribution patterns. In one hemithorax (yellow square), contrast was found in the subcutaneous space. L, left hemithorax; R, right hemithorax; D, dorsal; Cr, cranial; Cd, caudal; V, ventral.</p>
Full article ">Figure 7
<p>Computed tomography transverse images of three cat cadavers after performing an ultrasound-guided deep serratus plane block. (<b>A</b>) Image at the level of the fifth thoracic vertebra. Contrast media pooled in the target area between the serratus ventralis thoracis and intercostales externi muscles. (<b>B</b>) Image at the level of the fourth thoracic vertebra. Contrast media in the right hemithorax reach the epaxial muscles. (<b>C</b>) Image at the level of the sixth thoracic vertebra showing a combination of A and B patterns. Yellow arrow, contrast media; blue arrow, scapula; D, dorsal; LL, left lateral; RL, right lateral; V, ventral.</p>
Full article ">Figure 8
<p>Diagram of the number of nerves stained after performing the deep serratus plane block with a mixture of 0.4 mL kg<sup>−1</sup> of methylene blue and iopromide 50:50 in 12 cat cadavers. One hemithorax was excluded (red cross). L, left hemithorax; R, right hemithorax; T2, T3, T4, T5, T6, T7, and T9, spinal nerves; 1–12, cats 1–12.</p>
Full article ">Figure 9
<p>Distribution of dye in the deep serratus ventralis plane after the ultrasound-guided injection of a mixture of methylene blue and iopromide 50:50. RDL, rami laterales of the rami dorsales of the spinal nerves; RCL, rami cutanei laterales of the intercostales nerves; D, dorsal; Cr, cranial; Cd, caudal; V, ventral.</p>
Full article ">
16 pages, 441 KiB  
Systematic Review
The Management and Prevention of Delirium in Elderly Patients Hospitalised in Intensive Care Units: A Systematic Review
by Sarai Zaher-Sánchez, Pedro José Satústegui-Dordá, Enrique Ramón-Arbués, Jose Angel Santos-Sánchez, Juan José Aguilón-Leiva, Sofía Pérez-Calahorra, Raúl Juárez-Vela, Teresa Sufrate-Sorzano, Beatriz Angulo-Nalda, María Elena Garrote-Cámara, Iván Santolalla-Arnedo and Emmanuel Echániz-Serrano
Nurs. Rep. 2024, 14(4), 3007-3022; https://doi.org/10.3390/nursrep14040219 (registering DOI) - 15 Oct 2024
Viewed by 186
Abstract
Background: Delirium or an acute confusional state (ACS) is characterised as being a frequent and complex hospital complication in older adult patients, which can affect their level of independence and increase patient morbidity and mortality. Critically ill patients in the intensive care unit [...] Read more.
Background: Delirium or an acute confusional state (ACS) is characterised as being a frequent and complex hospital complication in older adult patients, which can affect their level of independence and increase patient morbidity and mortality. Critically ill patients in the intensive care unit (ICU) frequently develop ICU delirium, leading to longer hospital and ICU stays, increased mortality and long-term impairment. Objectives: This review aims to assess existing evidence of interventions that can be considered effective for the management and prevention of delirium in ICUs, reducing short-term morbidity and mortality, ICU and hospital admission times and the occurrence of other long-term complications. Methodology: For this systematic review, we searched Medline, PubMed, Cochrane Library, CINHAL, LILACS, SciELO and Dialnet from January 2018 to August 2024, in English, Spanish and French. MeSH descriptors were adjusted to search the different databases. We also checked Prospero for ongoing systematic reviews. Main results: The electronic search yielded a total of 2656 studies, of which 14 trials met the eligibility criteria, with a total of 14,711 participants. We included eight randomised clinical trial (RCTs), four cohort analyses, one systematic review and one observational trial, including participants over 65 years admitted to the ICU. Ten of these studies were based on pharmacological interventions, three of them examined non-pharmacological interventions and the remaining study examined mixed (pharmacological and non-pharmacological) interventions. Six placebo RCTs were included, plus four reported comparisons between different drugs. Regarding non-pharmacological interventions, nursing programmes focused on optimising modifiable risk factors or the use of therapies such as bright light are emerging. Regarding mixed interventions, we found the combination of invasive techniques and with sedoanalgesia. Conclusions: Due to its satisfactory level of sedation, dexmedetomidine is presented as a viable option because, although olanzapine offers safer results, postoperative administration angiotensin inhibitor systems significantly reduced the incidence of delirium. As for propofol, no significant differences were found. Among the non-pharmacological and mixed therapies, bright light therapy was able to reduce the incidence of delirium, and the combination of epidural/general anaesthesia was effective in all subtypes of delirium. Concerning the remaining interventions, the scientific evidence is still insufficient to provide a definitive recommendation. Full article
8 pages, 206 KiB  
Article
Postoperative Opioid Administration and Prescription Practices Following Hysterectomy in Two Tertiary Care Centres: A Comparative Cohort Study between Canada and Austria
by Judith Schiefer, Julian Marschalek, Djurdjica Djuric, Samantha Benlolo, Eliane M. Shore, Guylaine Lefebvre, Lorenz Kuessel, Christof Worda and Heinrich Husslein
J. Clin. Med. 2024, 13(20), 6031; https://doi.org/10.3390/jcm13206031 - 10 Oct 2024
Viewed by 382
Abstract
Background: In light of the opioid epidemic, opioid-prescribing modalities for postoperative pain management have been discussed controversially and show a wide variation across geographic regions. The aim of this study was to compare postoperative pain treatment regimes. Methods: We performed a matched cohort [...] Read more.
Background: In light of the opioid epidemic, opioid-prescribing modalities for postoperative pain management have been discussed controversially and show a wide variation across geographic regions. The aim of this study was to compare postoperative pain treatment regimes. Methods: We performed a matched cohort study of women undergoing hysterectomy in Austria (n = 200) and Canada (n = 200). We aimed to compare perioperative opioid medications, converted to morphine equivalent dose (MED) and doses of non-opioid analgesic (NOA) within the first 24 h after hysterectomy, and opioid prescriptions at discharge between the two cohorts. Results: The total MED received intraoperatively, in the post-anaesthesia care unit (PACU) and during the first 24 h after surgery, was similar in both cohorts (145.59 vs. 137.87; p = 0.17). Women in the Austrian cohort received a higher MED intraoperatively compared to the Canadian cohort (117.24 vs. 79.62; p < 0.001) but a lower MED in the PACU (25.96 vs. 30.42; p = 0.04). The primary outcome, MED within 24 h in the postoperative ward, was markedly lower in the Austrian compared to the Canadian cohort (2.36 vs. 27.98; p < 0.001). In a regression analysis, only the variables “Country” and “mode of hysterectomy” affected this outcome. A total of 98.5% in the Canadian cohort were given an opioid prescription at discharge vs. 0% in the Austrian cohort. Conclusions: Our analysis reveals marked differences between Austria and Canada regarding pain management practices following elective hysterectomy; the significantly higher intraoperative and significantly lower postoperative MED administration in the Austrian cohort compared to the Canadian cohort seems to be significantly affected by each country’s cultural attitudes towards pain management; this may have significant public health consequences and warrants further research. Full article
(This article belongs to the Section Obstetrics & Gynecology)
20 pages, 3124 KiB  
Review
Discrepancies between Promised and Actual AI Capabilities in the Continuous Vital Sign Monitoring of In-Hospital Patients: A Review of the Current Evidence
by Nikolaj Aagaard, Eske K. Aasvang and Christian S. Meyhoff
Sensors 2024, 24(19), 6497; https://doi.org/10.3390/s24196497 - 9 Oct 2024
Viewed by 349
Abstract
Continuous vital sign monitoring (CVSM) with wireless sensors in general hospital wards can enhance patient care. An artificial intelligence (AI) layer is crucial to allow sensor data to be managed by clinical staff without over alerting from the sensors. With the aim of [...] Read more.
Continuous vital sign monitoring (CVSM) with wireless sensors in general hospital wards can enhance patient care. An artificial intelligence (AI) layer is crucial to allow sensor data to be managed by clinical staff without over alerting from the sensors. With the aim of summarizing peer-reviewed evidence for AI support in CVSM sensors, we searched PubMed and Embase for studies on adult patients monitored with CVSM sensors in general wards. Peer-reviewed evidence and white papers on the official websites of CVSM solutions were also included. AI classification was based on standard definitions of simple AI, as systems with no memory or learning capabilities, and advanced AI, as systems with the ability to learn from past data to make decisions. Only studies evaluating CVSM algorithms for improving or predicting clinical outcomes (e.g., adverse events, intensive care unit admission, mortality) or optimizing alarm thresholds were included. We assessed the promised level of AI for each CVSM solution based on statements from the official product websites. In total, 467 studies were assessed; 113 were retrieved for full-text review, and 26 studies on four different CVSM solutions were included. Advanced AI levels were indicated on the websites of all four CVSM solutions. Five studies assessed algorithms with potential for applications as advanced AI algorithms in two of the CVSM solutions (50%), while 21 studies assessed algorithms with potential as simple AI in all four CVSM solutions (100%). Evidence on algorithms for advanced AI in CVSM is limited, revealing a discrepancy between promised AI levels and current algorithm capabilities. Full article
Show Figures

Figure 1

Figure 1
<p>Levels of artificial intelligence. Legends: Created in BioRender. Aagaard, N. (2024) BioRender.com/q01h863. Based on standardized AI definitions [<a href="#B26-sensors-24-06497" class="html-bibr">26</a>]. Pictures representing level II–V were created using DALL·E 3 (OpenAI, San Francisco, CA, USA).</p>
Full article ">Figure 2
<p>Prisma flow diagram showing the selection process of included articles.</p>
Full article ">Figure 3
<p>Number of peer-reviewed studies assessing algorithms for potential simple and advanced AI applications.</p>
Full article ">
9 pages, 727 KiB  
Article
Hypotension after Induction of Anesthesia as a Predictor of Hypotension after Opening the Dura Mater during Emergency Craniotomy
by Izabela Duda, Mariusz Hofman, Mikołaj Dymek, Piotr Liberski, Maciej Wojtacha and Anna Szczepańska
J. Clin. Med. 2024, 13(19), 6021; https://doi.org/10.3390/jcm13196021 - 9 Oct 2024
Viewed by 420
Abstract
Background: The subject of this study is intraoperative hypotension during the evacuation of acute subdural haematoma (ASH). We examined the association between the decrease in intraoperative blood pressure (BP) after the induction of anaesthesia and the decrease in BP after opening the dura [...] Read more.
Background: The subject of this study is intraoperative hypotension during the evacuation of acute subdural haematoma (ASH). We examined the association between the decrease in intraoperative blood pressure (BP) after the induction of anaesthesia and the decrease in BP after opening the dura mater. The second aim of this study was to assess the relationship between preoperative hypertension and the emergence of an intraoperative drop in BP. Methods: This was a retrospective cohort study on adult patients undergoing emergency craniotomy due to ASH. In total, 165 medical records from a 2-year period were analysed. The patients were divided into two groups: high blood pressure (HBP) (n = 89) and normal blood pressure (NBP) (n = 76). The HBP group included patients with hypertension in the preoperative period (systolic blood pressure (SBP) > 150 mmHg). The NBP group included patients with an SBP between 90 and 150 mmHg. Results: We observed a significant drop in blood pressure in two operational periods: after the induction of anaesthesia and after opening the dura mater. A highly relevant positive correlation was noted between the decrease in SBP after anaesthesia induction and the opening of the dura mater (p < 0.001). In the HBP group, after opening the dura mater, there was a 44% SBP decrease from the baseline value. Conclusions: The reduction in BP after the induction of anaesthesia is a predictor of a subsequent drop in BP after opening the dura mater during urgent surgery due to ASH. Patients with hypertension in the preoperative period of ASH tend to have a greater intraoperative drop in BP and worse outcomes. Full article
Show Figures

Figure 1

Figure 1
<p>Blood pressure values (systolic blood pressure, mean blood pressure and diastolic blood pressure: line max_min) and heart rate (dashed line) during emergency craniotomy due to acute subdural haematoma. Male patient aged 39; cause of injury: fall. The first decrease in blood pressure was noted after anaesthesia induction, and a second decrease occurred after opening the dura mater.</p>
Full article ">Figure 2
<p>Differences in systolic blood pressure (SBP) between the HBP and NBP groups at the examined operation points. <span class="html-italic">p</span> represents the difference in SBP between the NBP and HBP groups at the studied measurement point: B1—before the surgery, B2—after the induction of anaesthesia, B3—after opening the dura mater, and B4—after the surgery.</p>
Full article ">Figure 3
<p>Correlation between changes in systolic blood pressure (SBP) after anaesthesia induction (BP2) and after opening the dura mater (BP3); (<span class="html-italic">p</span> &lt; 0.0001; r = 0.3042).</p>
Full article ">
16 pages, 632 KiB  
Review
Post-Intensive Care Syndrome as a Burden for Patients and Their Caregivers: A Narrative Review
by Giovanni Schembari, Cristina Santonocito, Simone Messina, Alessandro Caruso, Luigi Cardia, Francesca Rubulotta, Alberto Noto, Elena G. Bignami and Filippo Sanfilippo
J. Clin. Med. 2024, 13(19), 5881; https://doi.org/10.3390/jcm13195881 - 2 Oct 2024
Viewed by 859
Abstract
Millions of critically ill patients are discharged from intensive care units (ICUs) every year. These ICU survivors may suffer from a condition known as post-intensive care syndrome (PICS) which includes a wide range of cognitive, psychological, and physical impairments. This article will provide [...] Read more.
Millions of critically ill patients are discharged from intensive care units (ICUs) every year. These ICU survivors may suffer from a condition known as post-intensive care syndrome (PICS) which includes a wide range of cognitive, psychological, and physical impairments. This article will provide an extensive review of PICS. ICU survivors may experience cognitive deficits in memory and attention, with a slow-down of mental processing and problem-solving. From psychological perspectives, depression, anxiety, and post-traumatic stress disorder are the most common issues suffered after ICU discharge. These psycho-cognitive impairments might be coupled with ICU-acquired weakness (polyneuropathy and/or myopathy), further reducing the quality of life, the ability to return to work, and other daily activities. The burden of ICU survivors extends to families too, leading to the so-called PICS-family (or PICS-F), which entails the psychological impairments suffered by the family and, in particular, by the caregiver of the ICU survivor. The development of PICS (and PICS-F) is likely multifactorial, and both patient- and ICU-related factors may influence it. Whilst the prevention of PICS is complex, it is important to identify the patients at higher risk of PICS, and clinicians should be aware of the tools available for diagnosis. Stakeholders should implement strategies to achieve PICS prevention and to support its effective treatment during the recovery phase with dedicated pathways and supporting care. Full article
(This article belongs to the Section Intensive Care)
Show Figures

Figure 1

Figure 1
<p>The “ABCDEFGH” bundle. The bundle is an evidence-based, multicomponent set of intensive care unit (ICU) interventions that could be applied to most patients and could have the value of reducing the burden of post-intensive care syndrome. SAT: spontaneous awakening trial; SBT: spontaneous breathing trial.</p>
Full article ">
10 pages, 1031 KiB  
Article
An Analysis of the Use of Anesthetic Blocks versus Local Anesthesia Infiltration in Primary Total Knee Arthroplasty Surgery
by Silvia Gomez Gomez, Julián C. Segura Mata, José T. Alcalá Nalváiz, Felicito García-Álvarez García, Clara Marín Zaldívar and Amagoia Fernández de Gamarra Goiricelaya
J. Clin. Med. 2024, 13(19), 5706; https://doi.org/10.3390/jcm13195706 - 25 Sep 2024
Viewed by 577
Abstract
Objectives: The aim of this study is to analyse the efficacy of using a combined infiltration between a popliteal artery and knee cap (IPACK) anaesthetic block and a selective saphenous nerve block compared to local infiltration with anaesthetic in knee replacement surgery. Methods: [...] Read more.
Objectives: The aim of this study is to analyse the efficacy of using a combined infiltration between a popliteal artery and knee cap (IPACK) anaesthetic block and a selective saphenous nerve block compared to local infiltration with anaesthetic in knee replacement surgery. Methods: A retrospective observational study was conducted. A total of 312 patients who underwent primary total knee arthroplasty in our hospital between January 2019 and December 2022 were reviewed. Local intra-articular anaesthesia was used in 207 patients and combined nerve block in 105 patients (IPACK group). The mean age in the LIA group was 72.9 years and 70.4 years in the IPACK group. There were 44% men in the LIA group and 53.3% in the IPACK group. The primary outcome was the presence of poorly controlled pain requiring rescue opioid analgesia in the postoperative period. Secondary outcomes included pain scores, range of motion and length of hospital stay. Results: There were no significant differences in the age or gender distribution of patients between the two groups. One patient treated with anaesthetic blocks required rescue analgesia with opioids, while in the LIA group this occurred in 28.5% of cases. There were statistically significant higher VAS scores in the LIA group (p < 0.001). Range of motion was slightly greater in the block group (4.6°, p < 0.05). There were significant differences in hospital stay (2.4 days in the blocks group and 2.8 days in the LIA group (p < 0.05). Conclusions: In our series, patients treated with anaesthetic blocks showed better results with similar postoperative pain control. However, further studies are needed. Full article
(This article belongs to the Section Anesthesiology)
Show Figures

Figure 1

Figure 1
<p>Rescue analgesia during surgery and in the hospital ward.</p>
Full article ">Figure 2
<p>VAS evolution after surgery.</p>
Full article ">Figure 3
<p>VAS 24 h.</p>
Full article ">
12 pages, 880 KiB  
Article
Biomarkers as Predictors of Mortality in Sepsis and Septic Shock for Patients Admitted to Emergency Department: Who Is the Winner? A Prospective Study
by Sonia Luka, Adela Golea, Raluca Mihaela Tat, Eugenia Maria Lupan Mureșan, George Teo Voicescu, Ștefan Cristian Vesa and Daniela Ionescu
J. Clin. Med. 2024, 13(19), 5678; https://doi.org/10.3390/jcm13195678 - 24 Sep 2024
Viewed by 811
Abstract
Background/Objectives: Sepsis and septic shock remain significant contributors to high early mortality rates among patients admitted to the emergency department (ED). The objective of this study was to identify among newer biomarkers those with the highest sensitivity in early mortality prediction. Methods [...] Read more.
Background/Objectives: Sepsis and septic shock remain significant contributors to high early mortality rates among patients admitted to the emergency department (ED). The objective of this study was to identify among newer biomarkers those with the highest sensitivity in early mortality prediction. Methods: This prospective, unicentric, observational study enrolled 47 adult patients admitted to the ED between November 2020 and December 2022. This study monitored the kinetics of the older and newer biomarkers, including azurocidin (AZU1), soluble triggering receptor expressed on myeloid cells (sTREM), soluble urokinase-type plasminogen activator receptor (suPAR), high-sensitivity C-reactive protein (hsCRP), procalcitonin (PCT), and interleukin-6 (IL-6), and their capacity in predicting mortality. Results: SuPAR showed the most significant predictive utility for early prognosis of mortality in the ED, with an area under the curve (AUC) of 0.813 (95% CI: 0.672 to 0.912), a cutoff value > 8168 ng/mL, sensitivity of 75%, and specificity of 81.48% (p < 0.001). IL-6 and PCT showed comparable prognostic accuracy, whereas hsCRP and AZU1 demonstrated lower predictive performance. Conclusions: In our study, suPAR, IL-6, and PCT showed good predictive value for short-term mortality in sepsis and septic shock patients. Full article
(This article belongs to the Special Issue New Diagnostic and Therapeutic Trends in Sepsis and Septic Shock)
Show Figures

Figure 1

Figure 1
<p>STROBE diagram of patient inclusion/exclusion criteria.</p>
Full article ">Figure 2
<p>AUCs for study biomarkers.</p>
Full article ">
10 pages, 1129 KiB  
Article
Agreement of Doppler Ultrasound and Visual Sphygmomanometer Needle Oscillation with Invasive Blood Pressure in Anaesthetised Dogs
by Marc Armour, Joanne Michou, Imogen Schofield and Karla Borland
Animals 2024, 14(19), 2756; https://doi.org/10.3390/ani14192756 - 24 Sep 2024
Viewed by 367
Abstract
Visual sphygmomanometer needle oscillation (SNO) can occur before audible return of pulsatile flow (ARPF) when measuring blood pressure by Doppler ultrasound. The aim was to assess the agreement of SNO and ARPF with invasive blood pressure (iABP) in a clinical population of anaesthetised [...] Read more.
Visual sphygmomanometer needle oscillation (SNO) can occur before audible return of pulsatile flow (ARPF) when measuring blood pressure by Doppler ultrasound. The aim was to assess the agreement of SNO and ARPF with invasive blood pressure (iABP) in a clinical population of anaesthetised dogs. A total of 35 dogs undergoing surgery in dorsal recumbency necessitating arterial cannulation were included. Paired measurements of iABP and SNO, and iABP and ARPF, were collected. The agreement of non-invasive blood pressure (NIBP) and iABP measurements was analysed with concordance correlation coefficients (CCCs) and Bland–Altman plots. The proportions of SNO and ARPF measurements between 10 and 20 mmHg of iABP were compared. Both SNO and ARPF demonstrated greater agreement with invasive systolic (iSAP) than invasive mean (iMAP) pressures, and SNO demonstrated greater agreement with iSAP than ARPF measurements. The mean differences (95% limits of agreement) for SNO and APRF were −9.7 mmHg (−51.3–31.9) and −13.1 mmHg (−62.2–35.9), respectively. The CCC (95% CI) for SNO was 0.5 (0.36–0.64) and ARPF was 0.4 (0.26–0.54). A significantly greater proportion of SNO measurements were within 20 mmHg of iSAP compared to ARPF. Both NIBP techniques performed more poorly than veterinary consensus recommendations for device validation. Caution should be used clinically when interpreting values obtained by Doppler ultrasound in anaesthetised dogs. Full article
(This article belongs to the Section Companion Animals)
Show Figures

Figure 1

Figure 1
<p>Overview of data collection.</p>
Full article ">Figure 2
<p>Bland–Altman plot for agreement between invasive systolic arterial pressure and audible return of pulsatile flow measurements.</p>
Full article ">Figure 3
<p>Bland–Altman plot for agreement between invasive systolic arterial pressure and sphygmomanometer needle oscillation measurements.</p>
Full article ">
13 pages, 566 KiB  
Article
Dysmenorrhea and Its Impact on Patients’ Quality of Life—A Cross-Sectional Study
by Mihaela Amza, Sebastian Findeklee, Bashar Haj Hamoud, Romina-Marina Sima, Mircea-Octavian Poenaru, Mihai Popescu and Liana Pleș
J. Clin. Med. 2024, 13(19), 5660; https://doi.org/10.3390/jcm13195660 - 24 Sep 2024
Viewed by 694
Abstract
Background: Dysmenorrhea is a common condition that may have negative effects on social life, couples’ relationships and professional activities. The objectives of this study were to evaluate the prevalence, risk factors and characteristics of dysmenorrhea and its impact on patients’ quality of life [...] Read more.
Background: Dysmenorrhea is a common condition that may have negative effects on social life, couples’ relationships and professional activities. The objectives of this study were to evaluate the prevalence, risk factors and characteristics of dysmenorrhea and its impact on patients’ quality of life using a specific self-questionnaire named “DysmenQoL questionnaire”. We also checked the validity and reliability of this questionnaire in our population. Methods: We conducted a cross-sectional study that included 504 participants of reproductive age between 18 and 45 years of age. The data were collected with an original form divided into three sections. The last section (DysmenQoL questionnaire) included 20 statements scored from 1 (“never”) to 5 (“every time”) that evaluates the effects of menstrual pain on health and feelings, daily activities, relationships and professional activity. We calculated the sum of the scores for each statement and we called it the “DysmenQoL score”. Results: The prevalence of dysmenorrhea was 83.7%. The presence of dysmenorrhea was statistically significant associated with the degree of menstrual bleeding (p = 0.017), the presence of infertility (p = 0.034) and dyspareunia (p = 0.002), but also with the presence of premenstrual syndrome and a family history of dysmenorrhea (p < 0.001). Among the participants with dysmenorrhea, 73.9% considered that this symptom affected their quality of life, and this was correlated with pain intensity and the DysmenQoL score (p < 0.001). A significant difference regarding the DysmenQoL score depending on the pain intensity, frequency and duration of dysmenorrhea and the methods used to reduce the pain was observed. Conclusions: Dysmenorrhea had a high prevalence among the participants included in the study, and its presence was associated with a series of risk factors. Most women considered that dysmenorrhea affected their quality of life. The DysmenQoL questionnaire proved to be a reliable and valid method for evaluating the impact of dysmenorrhea on quality of life. Full article
Show Figures

Figure 1

Figure 1
<p>The relationship between pain intensity and DysmenQoL score.</p>
Full article ">
17 pages, 3410 KiB  
Article
The Effects of the Pneumonia Lung Microenvironment on MSC Function
by Lanzhi Liu, Juan Fandiño, Sean D. McCarthy, Claire H. Masterson, Ignacio Sallent, Shanshan Du, Abigail Warren, John G. Laffey and Daniel O’Toole
Cells 2024, 13(18), 1581; https://doi.org/10.3390/cells13181581 - 20 Sep 2024
Viewed by 506
Abstract
Background: Despite promise in preclinical models of acute respiratory distress syndrome (ARDS), mesenchymal stem cells (MSC) have failed to translate to therapeutic benefit in clinical trials. The MSC is a live cell medicine and interacts with the patient’s disease state. Here, we explored [...] Read more.
Background: Despite promise in preclinical models of acute respiratory distress syndrome (ARDS), mesenchymal stem cells (MSC) have failed to translate to therapeutic benefit in clinical trials. The MSC is a live cell medicine and interacts with the patient’s disease state. Here, we explored this interaction, seeking to devise strategies to enhance MSC therapeutic function. Methods: Human bone-marrow-derived MSCs were exposed to lung homogenate from healthy and E. coli-induced ARDS rat models. Apoptosis and functional assays of the MSCs were performed. Results: The ARDS model showed reduced arterial oxygenation, decreased lung compliance and an inflammatory microenvironment compared to controls. MSCs underwent more apoptosis after stimulation by lung homogenate from controls compared to E. coli, which may explain why MSCs persist longer in ARDS subjects after administration. Changes in expression of cell surface markers and cytokines were associated with lung homogenate from different groups. The anti-microbial effects of MSCs did not change with the stimulation. Moreover, the conditioned media from lung-homogenate-stimulated MSCs inhibited T-cell proliferation. Conclusions: These findings suggest that the ARDS microenvironment plays an important role in the MSC’s therapeutic mechanism of action, and changes can inform strategies to modulate MSC-based cell therapy for ARDS. Full article
Show Figures

Figure 1

Figure 1
<p>Assessment of lung injury and inflammation in the sham (<span class="html-italic">n</span> = 11) and <span class="html-italic">E. coli</span> groups (<span class="html-italic">n</span> = 13). (<b>a</b>) Arterial oxygenation with 21% inspired oxygen was significantly lower in the <span class="html-italic">E. coli</span> group. (<b>b</b>) Lung compliance was significantly lower in the <span class="html-italic">E. coli</span> group compared to sham. (<b>c</b>) Protein concentration in BAL fluid was significantly higher in the <span class="html-italic">E. coli</span> group. (<b>d</b>) Protein concentration in pooled lung homogenate from the sham and <span class="html-italic">E. coli</span> groups showed no significant difference. (<b>e</b>) The level of CINC-1 in BAL fluid was significantly higher in the <span class="html-italic">E. coli</span> group (50.85, 27.66–72.69 vs. 190.0, 144.5–240.7 pg/mL). (<b>f</b>) The level of MMP-9 in BAL fluid was significantly higher in the <span class="html-italic">E. coli</span> group (91.05, 3.774–384.5 vs. 9969, 8382–17908 pg/mL). (<b>g</b>) The level of IL-6 in BAL fluid was significantly higher in the <span class="html-italic">E. coli</span> group (108.49 ± 102.72 vs. 549.60 ± 240.53 pg/mL). Results are shown as the minimum, first quartile, median, third quartile, and maximum, and analysed by two-tailed <span class="html-italic">t</span>-tests: ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001, or two-tailed Mann–Whitney test: ###: <span class="html-italic">p</span> &lt; 0.001; ####: <span class="html-italic">p</span> &lt; 0.0001. “ns” denotes non-significant differences.</p>
Full article ">Figure 1 Cont.
<p>Assessment of lung injury and inflammation in the sham (<span class="html-italic">n</span> = 11) and <span class="html-italic">E. coli</span> groups (<span class="html-italic">n</span> = 13). (<b>a</b>) Arterial oxygenation with 21% inspired oxygen was significantly lower in the <span class="html-italic">E. coli</span> group. (<b>b</b>) Lung compliance was significantly lower in the <span class="html-italic">E. coli</span> group compared to sham. (<b>c</b>) Protein concentration in BAL fluid was significantly higher in the <span class="html-italic">E. coli</span> group. (<b>d</b>) Protein concentration in pooled lung homogenate from the sham and <span class="html-italic">E. coli</span> groups showed no significant difference. (<b>e</b>) The level of CINC-1 in BAL fluid was significantly higher in the <span class="html-italic">E. coli</span> group (50.85, 27.66–72.69 vs. 190.0, 144.5–240.7 pg/mL). (<b>f</b>) The level of MMP-9 in BAL fluid was significantly higher in the <span class="html-italic">E. coli</span> group (91.05, 3.774–384.5 vs. 9969, 8382–17908 pg/mL). (<b>g</b>) The level of IL-6 in BAL fluid was significantly higher in the <span class="html-italic">E. coli</span> group (108.49 ± 102.72 vs. 549.60 ± 240.53 pg/mL). Results are shown as the minimum, first quartile, median, third quartile, and maximum, and analysed by two-tailed <span class="html-italic">t</span>-tests: ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001, or two-tailed Mann–Whitney test: ###: <span class="html-italic">p</span> &lt; 0.001; ####: <span class="html-italic">p</span> &lt; 0.0001. “ns” denotes non-significant differences.</p>
Full article ">Figure 2
<p>Apoptosis of BM-MSC after exposure to pooled lung homogenate. (<b>a</b>) Gating strategies with Annexin V-APC and Sytox Green. (<b>b</b>) Compared to the control (BM-MSCs cultured without lung homogenate), lung homogenate significantly induced apoptosis of BM-MSCs, especially in sham groups. In (<b>c</b>,<b>d</b>), the level of late apoptosis and necrosis of BM-MSC after exposure to lung homogenate in all groups was lower than 1%. Representative results of three independent experiments are shown as mean ± SD and analysed by two-way ANOVA with Šídák’s multiple comparisons test. **: <span class="html-italic">p</span> &lt; 0.01; ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001; ns: no significance.</p>
Full article ">Figure 3
<p>Activation of BM-MSC after exposure to pooled lung homogenate. (<b>a</b>,<b>b</b>) Expression level of CD54 (positive percentage) in viable BM-MSCs: CD54 positive percentage was significantly higher in lung homogenate groups, especially <span class="html-italic">E. coli</span> groups. (<b>c</b>,<b>d</b>) Expression level of CD119 (MFI) of viable BM-MSCs: CD119 MFI was significantly higher in <span class="html-italic">E. coli</span> groups than in the control and sham groups. (<b>e</b>,<b>f</b>) Expression level of CD200 (positive percentage) of viable BM-MSCs: CD200 positive percentage was significantly higher in lung homogenate groups, particularly in <span class="html-italic">E. coli</span> groups. (<b>g</b>,<b>h</b>) Negative expression of CD120b and CD274 on BM-MSCs in each group (<b>g</b>,<b>h</b>). Representative results of three independent experiments are shown as mean ± SD and analysed by two-way ANOVA with Šídák’s multiple comparisons test. ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 3 Cont.
<p>Activation of BM-MSC after exposure to pooled lung homogenate. (<b>a</b>,<b>b</b>) Expression level of CD54 (positive percentage) in viable BM-MSCs: CD54 positive percentage was significantly higher in lung homogenate groups, especially <span class="html-italic">E. coli</span> groups. (<b>c</b>,<b>d</b>) Expression level of CD119 (MFI) of viable BM-MSCs: CD119 MFI was significantly higher in <span class="html-italic">E. coli</span> groups than in the control and sham groups. (<b>e</b>,<b>f</b>) Expression level of CD200 (positive percentage) of viable BM-MSCs: CD200 positive percentage was significantly higher in lung homogenate groups, particularly in <span class="html-italic">E. coli</span> groups. (<b>g</b>,<b>h</b>) Negative expression of CD120b and CD274 on BM-MSCs in each group (<b>g</b>,<b>h</b>). Representative results of three independent experiments are shown as mean ± SD and analysed by two-way ANOVA with Šídák’s multiple comparisons test. ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 4
<p>Cytokine measurement in MSC-CM exposed to pooled lung homogenate. (<b>a</b>) Lung homogenate exposure significantly increased IL-8 concentration in MSC-CM; the level of IL-8 was significantly higher in <span class="html-italic">E. coli</span> groups at 100 and 200 µg/mL than in sham groups at the same concentrations. (<b>b</b>) The level of IL-6 in MSC-CM was significantly higher in the <span class="html-italic">E. coli</span> groups than in the control and sham groups at all concentrations. (<b>c</b>) Lung homogenate exposure significantly increased the release of MCP-1 in MSC-CM; the level of MCP-1 was significantly higher in <span class="html-italic">E. coli</span> groups at 200 µg/mL than in sham groups at the same concentration. (<b>d</b>) Lung homogenate exposure significantly increased the level of VEGF-A in MSC-CM; the level of VEGF-A was significantly higher in <span class="html-italic">E. coli</span> groups at 50 and 100 µg/mL than in sham groups at the same concentrations. (<b>e</b>,<b>f</b>) The level of TNFR1 and TGF-β1 in MSC-CM: No significant difference was detected between any groups. Representative results of three independent experiments are shown as mean ± SD and analysed by two-way ANOVA with Šídák’s multiple comparisons test. *: <span class="html-italic">p</span> &lt; 0.05; **: <span class="html-italic">p</span> &lt; 0.01; ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001; ns: no significance.</p>
Full article ">Figure 5
<p>Anti-microbial properties of CM from MSC exposed to pooled lung homogenate. (<b>a</b>) MSC-CM in all groups significantly inhibited the proliferation of <span class="html-italic">E. coli</span>. (<b>b</b>) MSC-CM in all groups significantly inhibited the proliferation of <span class="html-italic">K. pneumoniae</span>. (<b>c</b>) MSC-CM in all groups significantly inhibited the proliferation of <span class="html-italic">S. aureus</span>. Representative results of three independent experiments are shown as mean ± SD and analysed by two-way ANOVA with Šídák’s multiple comparisons test. ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 6
<p>T-cell proliferation with MSC-CM conditioned with pooled lung homogenate. (<b>a</b>) The proliferation model of CD3+CD4+ T-cells with Flowjo: CD3+CD4+ T-cells went through 5–6 generations. (<b>b</b>) The proliferation index of CD3+CD4+ T-cells: no significant differences were detected. (<b>c</b>) The expansion index of CD3+CD4+ T-cells: MSC-CM significantly inhibited CD3+CD4+ T-cells expansion, particularly in lung homogenate groups. (<b>d</b>) The proliferation model of CD3+CD8+ T-cells: CD3+CD8+ T-cells proliferated 5–6 generations. (<b>e</b>,<b>f</b>) The proliferation index and expansion index of CD3+CD8+ T-cells: MSC-CM inhibited CD3+CD8+ T-cells proliferation and expansion significantly in 50 µg/mL lung homogenate groups. MSC-CM from all lung homogenate groups significantly decreased the level of TNF-α (<b>g</b>), IFN-γ (<b>h</b>), and IL-10 (<b>i</b>) in PBMC culture media. Representative results of three independent experiments are shown as mean ± SD and analysed by two-way ANOVA with Šídák’s multiple comparisons test. *: <span class="html-italic">p</span> &lt; 0.001; **: <span class="html-italic">p</span> &lt; 0.01; ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001; ns: no significance.</p>
Full article ">Figure 6 Cont.
<p>T-cell proliferation with MSC-CM conditioned with pooled lung homogenate. (<b>a</b>) The proliferation model of CD3+CD4+ T-cells with Flowjo: CD3+CD4+ T-cells went through 5–6 generations. (<b>b</b>) The proliferation index of CD3+CD4+ T-cells: no significant differences were detected. (<b>c</b>) The expansion index of CD3+CD4+ T-cells: MSC-CM significantly inhibited CD3+CD4+ T-cells expansion, particularly in lung homogenate groups. (<b>d</b>) The proliferation model of CD3+CD8+ T-cells: CD3+CD8+ T-cells proliferated 5–6 generations. (<b>e</b>,<b>f</b>) The proliferation index and expansion index of CD3+CD8+ T-cells: MSC-CM inhibited CD3+CD8+ T-cells proliferation and expansion significantly in 50 µg/mL lung homogenate groups. MSC-CM from all lung homogenate groups significantly decreased the level of TNF-α (<b>g</b>), IFN-γ (<b>h</b>), and IL-10 (<b>i</b>) in PBMC culture media. Representative results of three independent experiments are shown as mean ± SD and analysed by two-way ANOVA with Šídák’s multiple comparisons test. *: <span class="html-italic">p</span> &lt; 0.001; **: <span class="html-italic">p</span> &lt; 0.01; ***: <span class="html-italic">p</span> &lt; 0.001; ****: <span class="html-italic">p</span> &lt; 0.0001; ns: no significance.</p>
Full article ">
30 pages, 808 KiB  
Review
Artifact Management for Cerebral Near-Infrared Spectroscopy Signals: A Systematic Scoping Review
by Tobias Bergmann, Nuray Vakitbilir, Alwyn Gomez, Abrar Islam, Kevin Y. Stein, Amanjyot Singh Sainbhi, Logan Froese and Frederick A. Zeiler
Bioengineering 2024, 11(9), 933; https://doi.org/10.3390/bioengineering11090933 - 18 Sep 2024
Viewed by 707
Abstract
Artifacts induced during patient monitoring are a main limitation for near-infrared spectroscopy (NIRS) as a non-invasive method of cerebral hemodynamic monitoring. There currently does not exist a robust “gold-standard” method for artifact management for these signals. The objective of this review is to [...] Read more.
Artifacts induced during patient monitoring are a main limitation for near-infrared spectroscopy (NIRS) as a non-invasive method of cerebral hemodynamic monitoring. There currently does not exist a robust “gold-standard” method for artifact management for these signals. The objective of this review is to comprehensively examine the literature on existing artifact management methods for cerebral NIRS signals recorded in animals and humans. A search of five databases was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The search yielded 806 unique results. There were 19 articles from these results that were included in this review based on the inclusion/exclusion criteria. There were an additional 36 articles identified in the references of select articles that were also included. The methods outlined in these articles were grouped under two major categories: (1) motion and other disconnection artifact removal methods; (2) data quality improvement and physiological/other noise artifact filtering methods. These were sub-categorized by method type. It proved difficult to quantitatively compare the methods due to the heterogeneity of the effectiveness metrics and definitions of artifacts. The limitations evident in the existing literature justify the need for more comprehensive comparisons of artifact management. This review provides insights into the available methods for artifact management in cerebral NIRS and justification for a homogenous method to quantify the effectiveness of artifact management methods. This builds upon the work of two existing reviews that have been conducted on this topic; however, the scope is extended to all artifact types and all NIRS recording types. Future work by our lab in cerebral NIRS artifact management will lie in a layered artifact management method that will employ different techniques covered in this review (including dynamic thresholding, autoregressive-based methods, and wavelet-based methods) amongst others to remove varying artifact types. Full article
(This article belongs to the Section Biosignal Processing)
Show Figures

Figure 1

Figure 1
<p>PRISMA flowchart of results for systematically conducted scoping review.</p>
Full article ">
Back to TopTop